Can-Fite BioPharma Ltd. Increase (Decrease) in Prepaid Expense and Other Assets
Can-Fite BioPharma Ltd. (CANF) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$195.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-03-26
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | -$195.00K 20-F · filed 2026-03-26 | ||
| 2025-06-30 | $73.00K 6-K · filed 2025-08-28 | ||
| 2024-12-31 | $109.00K 20-F · filed 2026-03-26 | ||
| 2024-06-30 | $114.00K 6-K · filed 2025-08-28 | ||
| 2023-12-31 | -$184.00K 20-F · filed 2026-03-26 | ||
| 2023-06-30 | $123.00K 6-K · filed 2024-08-29 | ||
| 2022-12-31 | $241.00K 20-F · filed 2025-04-14 | ||
| 2022-06-30 | $894.00K 6-K · filed 2023-08-31 | ||
| 2021-12-31 | -$128.00K 20-F · filed 2024-03-28 | ||
| 2020-12-31 | -$4.28M 20-F · filed 2023-03-30 | -$2.73M 20-F · filed 2021-03-25 | |
| 2019-12-31 | -$221.00K 20-F · filed 2022-03-24 | -$270.00K 20-F · filed 2021-03-25 | |
| 2018-12-31 | $853.00K 20-F · filed 2021-03-25 |